相关实验视频

Updated: Jul 11, 2025

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

在扩散性大B细胞淋巴瘤中T细胞参与抗体-最新消息

Shalini Balendran¹, Constantine Tam¹, Matthew Ku²

¹Alfred Health, Melbourne, VIC 3004, Australia.

Journal of clinical medicine

|November 14, 2023

概括

新型T细胞参与抗体 (TCEAbs) 对复发性/耐药性扩散性大B细胞淋巴瘤 (DLBCL) 显示出前景. 这些疗法利用免疫系统对抗癌症,目前正在研究它们的有效性和副作用的管理.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

扩散性大B细胞淋巴瘤 (DLBCL) 在复发/耐药 (R/R) 环境中提出了挑战.
新型细胞免疫疗法正在成为重要的治疗选择.

研究的目的:

审查DLBCL治疗中T细胞参与抗体 (TCEAbs) 的发展和作用机制.
检查临床试验数据,不良事件管理和TCEAbs.耐药性机制.

主要方法:

对R/R DLBCL的TCEAbs发表的临床试验数据的审查.
对TCEAb机制,疗效和安全性概况的分析.

主要成果:

TCEAbs在R/R DLBCL中表现出有希望的有效性,在重度预治疗的患者中实现完全缓解.
像blinatumomab这样的既定疗法为新型TCEAb开发铺平了道路.

结论:

在治疗R/RDLBCL方面,TCEAbs代表了显著的进步.
适当的识别和管理独特的毒性,如细胞因子释放综合征 (CRS) 和免疫效应细胞相关的神经毒性 (ICANS),对于成功治疗至关重要.

关键词:

汽车车上的车辆.DLBCL DLBCL 是一个字母.两种特异性的抗体.细胞因子释放综合征细胞因子释放综合征神经毒性的作用.耐火材料耐火材料耐火材料这是一个复发的复发.

更多相关视频

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

相关概念视频

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...